Renascience Inc.
Status: Publicly traded
Direct answer
Renascience Inc. is publicly traded on JPX under the ticker 4889.T.
Renascience Inc., established in 2000 and based in Tokyo, Japan, is actively engaged in pioneering and bringing to market pharmaceuticals and medical devices throughout Japan. The company's pipeline includes RS5614, a PAI-1 inhibitor that has reached Phase 3 clinical trials for a wide range of indications such as chronic myeloid leukemia, malignant melanoma, non-small cell lung cancer, novel coronavirus infections,...
Can you invest in Renascience Inc.?
Yes. Renascience Inc. trades publicly on JPX as 4889.T.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Renascience Inc.
Detailed equity research is provided by MarketSnap.